New cash-paying patients can now access Wegovy/Ozempic for $199 a month. Here's what that means for Novo Nordisk stock.

Signs of a weight loss price war appeared to worry investors early Monday, and Lilly and Novo stocks were down.

Novo Nordisk is lowering the price it charges customers who pay out-of-pocket for the weight loss drugs. Mr. Funk was the ...

Andy Richter is celebrating his “physical transformation” on Dancing With the Stars after decades of having his weight be ...

About one in eight American adults are now taking GLP-1 drugs like Ozempic, Wegovy, Zepbound, and Mounjaro, a new survey ...

Novo Nordisk is chopping prices again for its popular obesity treatment Wegovy, but doctors say the expense will remain ...

Novo Nordisk lowers Wegovy prices to $349 a month and adds temporary discounts, but doctors say costs remain tough for ...

Novo revealed Monday that the self-pay cost for the two lowest dosages of Wegovy and Ozempic will be $349 per month, down ...

Novo Nordisk announced it is cutting the cash-pay pricing for its popular semaglutide drugs: Wegovy will now be offered at ...

Trump announced popular weight loss treatments would be offered directly on a new “TrumpRx.gov” website at lower prices.

In a landmark deal announced this month, President Donald Trump negotiated dramatically lower costs for weight-loss drugs ...